Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 205 | 165 | 315 | 322 | 188 |
| Gross Profit | 205 | 165 | 315 | 322 | 188 |
| Operating Expenses | 987 | 849 | 981 | 1,400 | 1,188 |
| Operating Income | -782 | -684 | -666 | -1,078 | -1,000 |
| Interest Expense | 45 | 48 | 46 | 38 | 31 |
| Other Income | 0 | -1 | -1 | 38 | 0 |
| Pre-tax Income | -828 | -733 | -713 | -1,078 | -1,031 |
| Net Income Continuous | -828 | -733 | -713 | -1,078 | -1,031 |
| Net Income | $-828 | $-733 | $-713 | $-1,078 | $-1,031 |
| EBITDA(a) | $-780 | $-682 | $-663 | $-1,075 | $-997 |